MAML2 and central nervous system cancer: Although MAML2 polymorphisms were found to be significantly associated with the risk and prognosis of glioma, the mechanism of MAML2 underlying the effect on the glioma risk and patients survival was not identified in the present study, nor has not been reported in the literature.